Amarin Corporation PLC (AMRN) vs Sanofi (SNY)
- Amarin Corporation PLC AMRN 11.37 −1.73%
- Sanofi SNY 40.61 +0.79%
Amarin Corporation PLC and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $96.0B against $244.4M — 393.0× the size. Amarin Corporation PLC has negative trailing earnings, so its P/E is not meaningful; Sanofi trades at 21.3×. Sanofi grew revenue faster over the last twelve months: 21.3% against −15.1%. Sanofi has the higher net margin (8.22% vs −14.6%) and the higher return on invested capital (6.58% vs −19.8%). Across the 21 metrics below, Sanofi leads on 13 and Amarin Corporation PLC on 8.
Valuation
Profitability
| Metric | AMRN | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 41.96% | 72.78% | 72.77% |
| Operating margin | (21.89%) | 18.24% | 18.77% |
| Net margin | (14.56%) | 8.22% | 8.27% |
| Free cash flow margin | 8.36% | 25.53% | 17.18% |
| Return on equity | (5.97%) | 5.87% | 5.87% |
| Return on assets | (4.19%) | 3.21% | 2.57% |
| Return on invested capital | (19.79%) | 6.58% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack